Açıklama
Pre-clinical evidence from animal models of NAFLD treated with berberine demonstrates improvements in hepatic steatosis scores and liver enzyme levels compared to untreated controls, supporting anti-steatotic effects.
Figure 7
ChartSource Paper
Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Clinical and Pre-Clinical Overview and Systematic Review of the Literature.Cite This Figure
![Figure 7: Pre-clinical evidence from animal models of NAFLD treated with berberine demonstrates improvements in hepatic steatosis scores and liver enzyme levels compared to untreated controls, supporting anti-steatotic effects.]() > Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." *International journal of molecular sciences*, 2024. PMID: [38673787](https://pubmed.ncbi.nlm.nih.gov/38673787/)
<figure> <img src="" alt="Pre-clinical evidence from animal models of NAFLD treated with berberine demonstrates improvements in hepatic steatosis scores and liver enzyme levels compared to untreated controls, supporting anti-steatotic effects." /> <figcaption>Figure 7. Pre-clinical evidence from animal models of NAFLD treated with berberine demonstrates improvements in hepatic steatosis scores and liver enzyme levels compared to untreated controls, supporting anti-steatotic effects.<br> Source: Florentina Ionita-Radu et al. "Berberine Effects in Pre-Fibrotic Stages of Non-Alcoholic Fatty Liver Disease-Cl." <em>International journal of molecular sciences</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/38673787/">38673787</a></figcaption> </figure>